efzofitimod
·Code: KRP-R120
efzofitimod: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| aTYR PHARMA INC (ATYR) | Phase 3 |
FDA Decisions
FDA_MeetingCompany plans to engage with the FDA to review Phase 3 EFZO-FIT results and determine the path forward for efzofitimod in pulmonary sarcoidosis.(ATYR)
Frequently asked questions
Who is developing efzofitimod?
efzofitimod is being developed by aTYR PHARMA INC.
What is efzofitimod's latest FDA decision?
The most recent tracked FDA decision for efzofitimod is FDA_Meeting for Company plans to engage with the FDA to review Phase 3 EFZO-FIT results and determine the path forward for efzofitimod in pulmonary sarcoidosis..
Get deeper analysis on efzofitimod
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis